Protalix BioTherapeutics (PBDA.F) Competitor Comparison
We are evaluating the key criteria listed to compare Protalix BioTherapeutics (PBDA.F) against its competitors in the Biotechnology industry.
Market Capitalization
262 / 368Gross Profits
75 / 278Total Revenue
109 / 300EBITDA
27 / 337Free Cashflow
84 / 352Quick Ratio
323 / 357Earnings per Share
32 / 359Dividend yield
0 / 6Total Cash
273 / 358Performance 3 years
128 / 368Performance 5 years
217 / 368Performance 10 years
307 / 368Linearity 3 years
41 / 368Linearity 5 years
182 / 368Linearity 10 years
290 / 368Total Rank
237 / 368Dividend Rank
247 / 368Valuation Rank
110 / 368Piotroski Rank
208 / 368Muliplier Rank
22 / 368Linearity 5 years - PBDA.F ranking 182 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.